KBW maintains Outperform on RLI, raises price target to $70
Keefe, Bruyette & Woods analyst Meyer Shields maintained an Outperform rating on RLI and raised the price target from $67 to $70, indicating a positive outlook for the NYSE-listed insurer.

*this image is generated using AI for illustrative purposes only.
Keefe, Bruyette & Woods analyst Meyer Shields has maintained an Outperform rating on RLI while raising the price target to $70. The previous target was $67. The rating and target adjustment reflect the firm's updated outlook on the insurer's performance.
Rating and Target Details
The decision by Keefe, Bruyette & Woods underscores confidence in RLI's market position. The revised price target suggests potential upside from current trading levels.
| Metric | Value |
|---|---|
| Rating | Outperform |
| Previous Price Target | $67 |
| New Price Target | $70 |
RLI trades on the NYSE under the ticker symbol RLI.
What specific factors are driving the updated outlook for RLI's performance?
How might RLI's market position evolve in the current economic climate?
What are the potential risks that could impact RLI's ability to meet the new price target?



























